تجاوز إلى المحتوى الرئيسي
User Image

عبدالله بن خالد الشميمري | Abdullah K. Alshememry

Associate Professor

وكيل كلية الصيدلة للشؤون التعليمية والأكاديمية

كلية الصيدلة
أستاذ مشارك في التقنية الحيوية الصيدلية - قسم الصيدلانيات
المنشورات
مقال فى مجلة
2021

Design and Development of (TPGS−b−PCL) Nanocarriers for Solubilization and Controlled Release of Paclitaxel

Abstract: The objective of this study was to synthesize and characterize a set of biodegradable
block copolymers based on TPGS-block-poly("-caprolactone) (TPGS-b-PCL) and to assess their selfassembled
structures as a nanodelivery system for paclitaxel (PAX). The conjugation of PCL to TPGS
was hypothesized to increase the stability and the drug solubilization characteristics of TPGS micelles.
TPGS-b-PCL copolymer with various PCL/TPGS ratios were synthesized via ring opening bulk
polymerization of "-caprolactone using TPGS, with different molecular weights of PEG (1-5 kDa),
as initiators and stannous octoate as a catalyst. The synthesized copolymers were characterized
using 1H NMR, GPC, FTIR, XRD, and DSC. Assembly of block copolymers was achieved via the
cosolvent evaporation method. The self-assembled structures were characterized for their size,
polydispersity, and CMC using dynamic light scattering (DLS) technique. The results from the
spectroscopic and thermal analyses confirmed the successful synthesis of the copolymers. Only
copolymers that consisted of TPGS with PEG molecular weights 2000 Da were able to self-assemble
and form nanocarriers of 200 nm in diameter. Moreover, TPGS2000-b-PCL4000, TPGS3500-b-PCL7000,
and TPGS5000-b-PCL15000 micelles enhanced the aqueous solubility of PAX from 0.3 g/mL up
to 88.4 ug/mL in TPGS5000-b-PCL15000. Of the abovementioned micellar formulations, TPGS5000-
b-PCL15000 showed the slowest in vitro release of PAX. Specifically, the PAX-loaded TPGS5000-b-
PCL15000 micellar formulation showed less than 10% drug release within the first 12 h, and around
36% cumulative drug release within 72 h compared to 61% and 100% PAX release, respectively, from
the commercially available formulation (Ebetaxel®) at the same time points. Our results point to a
great potential for TPGS-b-PCL micelles to efficiently solubilize and control the release of PAX.

مجلة/صحيفة
Molecules
مزيد من المنشورات
publications

Development of elastin-like polypeptide (ELP) biomaterials is widespread, but information critical for clinical deployment is limited, with biocompatibility studies focused on a narrow cross-…

2021
publications

Jatropha pelargoniifolia (JP) is a medicinal plant that is widely used in traditional medicine owing to its broad range of therapeutic activities. Despite its promising pharmacological activities…

2021
publications

Abstract: The objective of this study was to synthesize and characterize a set of biodegradable
block copolymers based on TPGS-block-poly("-caprolactone) (TPGS-b-PCL) and to assess their…

2021